ArticleFrontiers in immunology2017

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells.

Xueheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.